FDP
PTCT icon

Financiere des Professionnels’s PTC Therapeutics PTCT Stock Holding History

Financiere des Professionnels’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$492K Buy
7,228
+1,407
+24% +$99.6K 0.03% 239
2025
Q4 		$442K Hold
5,821
– – 0.03% 229
2025
Q3 		$357K Hold
5,821
– – 0.02% 260
2025
Q2 		$284K Buy
+5,821
New +$276K 0.02% 254

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Financiere des Professionnels's PTCT Position: Q1 2026 in Review

Financiere des Professionnels increased its PTC Therapeutics (PTCT) stake by 24% in Q1 2026, buying an estimated $99.6K and bringing the position to 7,228 shares worth $492K. The position accounts for 0.03% of the portfolio, ranked #239.

Financiere des Professionnels first reported a position in PTCT in Q2 2025 and has held it in 4 quarters since. 349 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Financiere des Professionnels held 7,228 shares of PTC Therapeutics worth $492K as of Q1 2026.
  • Financiere des Professionnels bought 1,407 PTC Therapeutics shares in Q1 2026, an estimated $99.6K.
  • PTC Therapeutics made up 0.03% of Financiere des Professionnels's portfolio in Q1 2026, its #239 holding.
  • Financiere des Professionnels first reported a position in PTC Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 349 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Financiere des Professionnels's 13F filing for Q1 2026, filed 6 May 2026.